Skip to Content

Amphadase Amphastar Pharmaceuticals, Inc - Treatment for Adjunctive Agent

Amphadase (formulated as a replacement for Wydase which was discontinued in 2001) contains hyaluronidase, an enzyme that breaks down hyaluronic acid in connective tissue, increasing tissue permeability. Hyaluronidase is typically used as an adjunctive agent to facilitate the dispersion and absorption of other drugs.

Posted: October 2004

Amphadase (hyaluronidase) FDA Approval History